OctoPlus feels the market pressure

30-Nov-2007 - Dutch drug delivery and development company OctoPlus is withdrawing its follow-on financing on its five-strong product portfolio in response to the US mortgage crisis and the struggling stock market.

Pharmaceutical manufacturing: news in brief

30-Nov-2007 - In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry.

Jubilant Organosys eyeing up European acquisitions

30-Nov-2007 - Indian pharma services provider Jubilant Organosys is looking to buy up European contract research organisations (CRO) and contract research and manufacturing services (CRAMS) and it has got $100m to spend,...

Product news in brief - week 48

29-Nov-2007 - LabTechnologist.com brings you a round up of recent product releases, with new offering from Agilent, Applied Biosystems, Grabner, Jeol USA and Velocity11.

A spoonful of foam helps the medicine go down

29-Nov-2007 - Is it a liquid? Is it a solid?………No, it's 'foam-on-a-spoon'.

Merck heads to Ireland for new 200m site

29-Nov-2007 - Merck has settled on a site in south east Ireland for a new vaccines and biologics facility, investing €200m ($280m) in its third facility on the island.

'Technology Pioneers' elected to World Economic Forum

29-Nov-2007 - The World Economic Forum has announced this year's 'Technology Pioneers', firms which have developed a life-changing technology innovation that has the potential for long-term impact on both business and society.

Asylum Research in the dock over Veeco's patent claims

29-Nov-2007 - Veeco's patent infringement case against Asylum Research is set to go to court after a US Court ruled that three of Veeco's atomic force microscopy (AFM) patents were potentially being...

Akorn and Cipla team up again

27-Nov-2007 - Specialty pharmaceutical company Akorn has signed up with India-based Cipla in an exclusive manufacturing and supply agreement for an undisclosed inhaled drug.

Contract manufacturing news in brief

27-Nov-2007 - Dr Reddy's, China Aoxing Pharmaceutical, Cook Pharmica and Alpha Biologics have all recently announced contract manufacturing news.

PolyTherics gets funding for antibody fragments

27-Nov-2007 - PolyTherics has been boosted with £350,000 ($723,135) in funding to explore the development and production of long-lasting therapeutic antibody fragments.

Nano-flares light the way for in-cell mRNA detection

27-Nov-2007 - Researchers have developed a nanoparticle signalling system that can be used as cellular 'nano-flares' that enable the visualisation and quantification of RNA in living cells.

Chromatide wins GRAND grant for enzyme-catalysis development

27-Nov-2007 - Chromatide has been awarded a grant to help it develop an enzyme immobilisation method using its unique polymer systems that should enable them to be used in flow-chemistry systems.

Astellas snaps up cancer antibody specialists Agensys

27-Nov-2007 - Japanese drugmaker Astellas has agreed to acquire US biotech firm Agensys as part of its plan to ramp up antibody research, especially in the field of cancer.

Industry news in brief - week 48

27-Nov-2007 - LabTechnologist.com brings you a review of the latest industry news, with developments at Arrayjet, Celera, Inverness, Plasticell, Qiagen and ThalesNano.

ERC to provide 4bn Euros for 'far-reaching research'

27-Nov-2007 - The European Research Council (ERC) has announced it will fund Europe's very best research projects to the tune of €4bn in a bid to improve Europe's position at the frontiers...

AstraZeneca finds buyer for German plant

27-Nov-2007 - Reports emerged in the German press yesterday claiming that AstraZeneca has found a buyer for its Plankstadt manufacturing facility.

Weekly Comment

Paediatric drugs and testing highlighted

26-Nov-2007 - The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego.

Sanofi expands flu vaccines in China

26-Nov-2007 - Sanofi-Aventis is to build a new influenza vaccine manufacturing facility in China.

MHRA launches new action plan to combat UK counterfeit hub

26-Nov-2007 - The UK has become an unlikely hub for drug counterfeiters, with the UK Medicines and Healthcare products Regulatory Agency (MHRA) last week launching its new three-year action plan to tackle...

Singapore's pharma output continues to slow

26-Nov-2007 - Singapore's biomedical manufacturing output was down again over October, stunting growth for the region's entire manufacturing sector.

Exploring protein interactions in 'technicolour'

26-Nov-2007 - A triple-colour bioluminescent assay has been developed that promises to speed-up high content screening (HCS) analysis by enabling multiple-target monitoring.

GSK buys Reliant for cardiovascular drugs

23-Nov-2007 - GlaxoSmithKline (GSK) has acquired Reliant Pharmaceuticals for $1.65bn in a bid to improve its cardiovascular therapy portfolio.

Pharma should keep outsourcing in mind

23-Nov-2007 - The pharmaceutical industry is backward when it comes to outsourcing, industry experts said at the American Association of Pharmaceutical Scientists (AAPS) conference in San Diego last week.

Schott takes aim at Russia

23-Nov-2007 - Pharmaceutical packaging specialist Schott has announced plans to head to Russia and establish its first pharma production site in the country.

Regulators slate Roche 'lack of knowledge and understanding' in Viracept contamination case

23-Nov-2007 - The official report into good manufacturing practice (GMP) failures that caused dangerous contamination and a Europe-wide recall of Roche's HIV drug Viracept (nelfinavir) claims the firm simply did not understand...

Pharmaceutical manufacturing: news in brief

23-Nov-2007 - In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry.

Product news in brief - week 47

22-Nov-2007 - LabTechnologist.com brings you a round up of the latest product releases, with new offerings from Bio-Rad, KD Scientific, Micronic, Millipore, Q Chip, Thermo Fisher Scientific and Warner Instruments.

Boehringer Ingelheim takes on prefilled syringes

22-Nov-2007 - Boehringer Ingelheim has added to its contract services with the manufacture, fill and finish capacity for drugs in prefilled syringes.

Termites suggest route to new biofuel bioreactors

22-Nov-2007 - The quest for more efficient methods of generating biofuels has been boosted by a metagenomic study of the gut bacteria that enable termites to digest wood.

Recipharm rescues Ashton Pharma

22-Nov-2007 - Recipharm has come to rescue of UK-based Ashton Pharma, which has been nervously awaiting to discover its fate, having spent five months in administration after its former owners Inyx Inc....

FMC improves on existing excipients

22-Nov-2007 - FMC BioPolymer has introduced two new excipient products to the pharma market - the first in two years.

Take off immune system brake to improve cancer vaccines

22-Nov-2007 - The discovery of a new molecule that can act as a brake for the immune system could lead to new therapies for cancer and autoimmune diseases such as diabetes.

Pharmaceutical patent round-up

22-Nov-2007 - In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations.

Mr Gene designs and orders constructs in minutes

22-Nov-2007 - Geneart has launched the first fully on-line gene construct design and ordering system, dubbed Mr Gene, which is targeting the emerging 'low-price' segment of the synthetic biology market.

Cisbio licenses 'universal' kinase assay platform

21-Nov-2007 - Cisbio has licensed BellBrook Labs' ADP immunodetection technology for use in its HTRF screening system that will enable researchers to study the activity of any protein kinase.

Pharmaceutical manufacturing: people on the move

21-Nov-2007 - Alfacell, Phoqus Pharmaceuticals, Watson Pharmaceuticals, Stem Cell Sciences, Kythera Biopharmaceuticals and ISPE have all had people on the move in the world of pharmaceutical manufacturing.

Men get the heads up on possible oral contraceptive

21-Nov-2007 - It might be years away yet, but men could be the ones popping a pill for contraception if GTx has anything to do with it.

Puerto Rico's problems piling up

21-Nov-2007 - Pfizer's revelation this week that it plans to slice jobs in Puerto Rico is the latest in a string of blows for this popular offshore manufacturing location.

Pandemic flu vaccine supply inadequate, says report

21-Nov-2007 - The current state of pandemic influenza vaccine supplies and capacity is shockingly insufficient, a new report has found - less than one-fifth of needed doses would actually be available within...

Biovail knocked back by FDA decision

21-Nov-2007 - Canadian firm Biovail has been thrown another curveball by US regulators as the resubmission for its antidepressant candidate is handed Class 2 status, delaying approval for at least another six months.

Weekly Comment

South Africa 'underutilised' for clinical trials

20-Nov-2007 - While India, the Asia-Pacific, Eastern Europe and Latin America are all gaining recognition as potential new hot spots, South Africa remains 'underutilised as a clinical trial destination,' according to a...

Simultaneous measurement of multiple cytokines

20-Nov-2007 - Researchers at Randox, UK, have developed a biochip that enables the simultaneous measurement of 12 human cytokines from human serum samples enabling cytokine studies to be conducted faster.

Industry news in brief - week 47

20-Nov-2007 - LabTechnologist.com brings you a round up of recent industry news, with developments at Advanced Instruments, Aperio, Applied Biosystems, Beckman Coulter, Bruker, Invitrogen, Roche, TCS Cellworks and Thermo Fisher Scientific.

NanoSight sizes up to nanotoxicology challenges

20-Nov-2007 - NanoSight's particle size analysers have found in a new home in the laboratories of 'nanotoxicologists' due to their ease of use and rapid ability to size and count individual nanoparticles.

Blast at Aesica London plant

20-Nov-2007 - Contract manufacturer Aesica has confirmed reports of a blast at its Ponders End facility in North London last night, hospitalising three workers.

CML snaps up API services firm

20-Nov-2007 - Cambridge Major Laboratories (CML) has bought up a Dutch supplier of active pharmaceutical ingredient (API) development services, creating one of the largest pharma chemistry development organisations in the western hemisphere.

Kids' vaccine market set to quadruple

20-Nov-2007 - A recent report suggests that the market for paediatric and adolescent vaccines is set to grow four-fold over the next decade, spearheaded by Wyeth's Prevnar as the first blockbuster vaccine.

Formulation tech goes Enterion

20-Nov-2007 - The Enterion capsule is quickly becoming big pharma's new best friend as the technology helps drug companies assess the feasibility of oral modified release formulations.

Researcher recognised for studies in drug delivery

20-Nov-2007 - Dr Mitsuru Hashida is hoping his studies into drug delivery will be useful for the pharmaceutical industry.

Cystatin C can wash away Alzheimer's plaques

20-Nov-2007 - Scientists have discovered that a protein called cystatin C can prevent damaging Alzheimer's plaques from forming by keeping their constituent protein water soluble.

Cancer antibody marches on quoths Raven Biotechnologies

20-Nov-2007 - Raven Biotechnologies have announced positive initial clinical trial results for their anticancer antibody that causes tumour cells to swell up and die.

APIcross goes solo in drug delivery

19-Nov-2007 - Contract pharmaceutical development company Azopharma has carved out its drug delivery segment into a new company, APIcross Drug Delivery Technologies.

NeoMPS gets acquired

19-Nov-2007 - PolyPeptide Laboratories Group is to acquire the peptide manufacturing group NeoMPS.

Pfizer saves Coley with $164m buyout

19-Nov-2007 - After a clinical hiccough five months ago set Coley Pharmaceutical's drug development funding back several years, Pfizer has stepped in to save the day, snapping up the biotech for $164m.

J&J Belgium suffers strike over job cuts

19-Nov-2007 - Workers at Johnson & Johnson's (J&J's) Belgium subsidiary went on strike today in protest at the compensation being offered to those at the firm falling foul of the dreaded pharma...

Pipeline match following Celgene's $2.9bn acquisition of Pharmion

19-Nov-2007 - Celgene has agreed to pay $2.9bn for Pharmion in the hope of becoming a 'global leader in the haematology and oncology field', but do the company's pipelines match up well...

J&J rejigs

16-Nov-2007 - Johnson & Johnson (J&J) has announced plans to revamp its organisation in a bid to address the "new environment" emerging in human healthcare.

Pharmaceutical manufacturing: news in brief

16-Nov-2007 - In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry.

Mega deal creates largest pharma player in CEE

16-Nov-2007 - Hungarian pharma Gedeon Richter has announced plans to combine with Polish firm Polpharma to create a major presence in Central Eastern Europe (CEE) through a share deal worth HUF231bn ($1.3bn)....

Product news in brief - week 46

15-Nov-2007 - LabTechnologist.com brings you its periodic update of new product releases, with offerings from Bio-Rad, BTX, Hitachi, Mettler Toledo, Syrris, Thermo Fisher Scientific, Tripos Intl., Warner and Whitehouse.

Fluorotechnics buys into electrophoresis market

15-Nov-2007 - Australian proteomics fluorescence expert Fluorotechnics has acquired ETC Elektrophorese-Technik to gain access to the company's electrophoresis expertise and product lines.

Stem cell breakthrough avoids the embryo controversy

15-Nov-2007 - US researchers have developed a way of creating primate embryonic stem cells that avoids the need to use fertilised embryos, potentially leading to more ethical ways of curing degenerative diseases.

Extra breathing space for epinephrine MDI ban

15-Nov-2007 - The US Food and Drug Administration (FDA) has given stakeholders an extra month to get their views in on scrapping epinephrine inhalers containing CFCs.

Icahn invests in Genzyme, prompts takeover rumours

15-Nov-2007 - The man often credited with causing Biogen Idec to be put up for sale, billionaire corporate raider Carl Icahn, has invested in Genzyme and promptly started industry tongues wagging about...

AMRI continues growth

15-Nov-2007 - Albany Molecular Research Inc (AMRI) recently turned in Q3 results, posting figures buoyed by continued demand for its pharmaceutical development services.

Pfizer, Nektar agreement not so sweet after all?

14-Nov-2007 - Pfizer yesterday announced a multi-million dollar pay-off to ex-partner Nektar Therapeutics, but the details of the deal reveal not only Nektar's concerns for its future, but also that Pfizer is...

Accelrys offers academics its scientific operating system for free

14-Nov-2007 - Accelrys is offering its SciTegic scientific operating system to academics for free to enable them to create software applications and share them with both academic and commercial communities.

Pharmaceutical manufacturing: people on the move

14-Nov-2007 - AstraZeneca, Cumberland Pharmaceuticals, Pieris, Theraptosis and InteKrin Therapeutics have all had people on the move in the world of pharmaceutical manufacturing.

Applied Biosystems and BioTrove form HT genotyping alliance

13-Nov-2007 - Applied Biosystems and BioTrove have signed a licensing and collaboration agreement to commercialise an analysis platform for high-throughput (HT) genotyping applications.

Nanogen scraps microarray business in favour of PCR assays

13-Nov-2007 - Nanogen has decided to pull the plug on its microarray business after not finding any 'financially meaningful opportunities' for it, reducing staff by 20 per cent in the process.

Industry news in brief - week 46

13-Nov-2007 - LabTechnologist.com brings you a round up of the latest industry news, with developments at Abcam, Applied Isotope Technologies, Horiba, Invitrogen, Jasco, NIH, Sloning and VWR.

PharmEng opens new Canada plant

13-Nov-2007 - Canadian contract manufacturer PharmEng recently announced that its new specialised manufacturing facility in Nova Scotia is open for business.

China gets serious on drug GMP; safety pact with FDA imminent

13-Nov-2007 - As of next year Chinese pharmaceutical manufacturers will face a tougher time gaining good manufacturing practice (GMP) certification after the country's regulator signalled new and stricter standards were on the...

NPIL to trim ex-Pfizer site

13-Nov-2007 - NPIL Pharma last week told workers at its former Pfizer plant in Morpeth, UK that the company is considering hiving off jobs in a bid to maintain the site's viability.

AstraZeneca in 'serious trouble', say analysts

13-Nov-2007 - An analyst report released yesterday identified AstraZeneca as being in 'serious trouble' and branded it as potentially the 'worst [large cap] performer in [the] entire sector' over the next eight...

Artel finds Death Valley's heat devastates accurate pipetting

13-Nov-2007 - Artel's third 'Extreme Pipetting' expedition went to Death Valley, US, to see the size of errors that dry heat would introduce to pipetted volumes and found they could be as...

Practice run for pharma RFID

13-Nov-2007 - IBM has teamed up with RFID specialist Tagsys to offer pharmaceutical manufacturers a chance to have a practice run implementing their RFID track and trace technology ahead of new legal...

WHO talks on research strategy for developing world diseases stall

12-Nov-2007 - Talks between World Health Organization (WHO) member states and the drug industry over how to narrow the health gap between rich and poor countries have stalled.

BAC looks to enhance laboratory purification with new antibody toolkit

12-Nov-2007 - Bio Affinity Company (BAC) has launched a new antibody purification toolbox based on its successful industrial-scale technology to provide researchers with a simpler purification route.

$60m expansion for mystery pharma

12-Nov-2007 - Swedish construction firm Skanska today announced that it has been awarded a multi-million dollar contract to expand a pharmaceutical facility in the US, though the company is keeping the identity...

AstraZeneca axes packaging plant

12-Nov-2007 - AstraZeneca's axe has made its latest appearance in South Africa, with the sale of a packaging plant and the formation of an outsourcing deal with its new owners.

Hefty price hike for BASF excipients

12-Nov-2007 - German chemicals firm BASF has announced a major price hike across its range of pharmaceutical excipients, upping price tags by as much as 9 per cent.

Biovail keeps head above water

09-Nov-2007 - Although the Canadian drug delivery specialist yesterday released third quarter results showing revenues down on last year, operating income is on the up despite generic competition and recent stumbles for...

ProMetic techs for next generation hyperimmunes

09-Nov-2007 - Italian biopharmaceutical firm Kedrion is set to sign a deal with ProMetic BioTherapeutics to gain access to the firm's manufacturing technologies to increase yield and reduce prions in its hyperimmune...

Pharmaceutical manufacturing: news in brief

09-Nov-2007 - In-PharmaTechnologist.com brings you a selection of other headlines from the pharmaceutical manufacturing industry.

Wacker expands further into biologics

09-Nov-2007 - Biopharmaceutical contract manufacturer Wacker will be expanding its German facility in Jena for €15m ($22m) as it meets demand for biologics.

Agilent buys Velocity11 for the 'ultimate automation experience'

08-Nov-2007 - Agilent has signed a definitive agreement to acquire automation expert Velocity11 for an undisclosed amount to enable it to speed up drug discovery and genomics research.

Product news in brief - week 45

08-Nov-2007 - LabTechnologist.com brings you its periodic round up of product news, with new releases from Affymetrix, Agilent, AnaSpec, Applied Biosystems, Axiom, Bio-Rad, KD Scientific, Millipore and Oxoid.

The sweet taste of analysing biological drugs

08-Nov-2007 - Researchers from Amgen have published results detailing a method that improves the analysis of the sugar groups attached to monoclonal antibodies (MAbs) and proteins.

P&G in shock nasal spray exit

08-Nov-2007 - Procter & Gamble (P&G) has this week terminated an agreement with Nastech to develop a nasally delivered version of Eli Lilly's osteoporosis drug Forteo (teriparatide), leaving its partner with no...

Add PEG to make the drug go farther

08-Nov-2007 - A US research team has found a way to increase drug distribution in the brain to fight the recurrence of human brain tumours.

'World's first' NanoImaging service centre opens

08-Nov-2007 - NanoImaging Services has opened what it claims is a first of its kind fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development pipeline.

Merck HIV vaccine failure puts cold virus on trial

08-Nov-2007 - Merck & Co's failed HIV vaccine may actually increase the risk of infection and the latest data raises questions over whether the cold virus used as a delivery technique was...

Genentech named facility of the year winner

08-Nov-2007 - US biotechnology company Genentech is filling its trophy cupboard again after being named the winner of the 2007 Facility of the Year Award.

West unscathed by Exubera shot - for now

08-Nov-2007 - West Pharmaceutical Services, one of the two firms responsible for manufacturing Pfizer's failed Exubera device, recently turned in its third quarter financials, so far avoiding any major dent from the...

Sanofi pushes on with cell culture flu shot

07-Nov-2007 - Sanofi Pasteur has kicked off Phase II trials of its cell culture-based seasonal flu vaccine in the US, part of a five year project with the US Department of Health...

Pharmaceutical manufacturing: people on the move

07-Nov-2007 - MedImmune, Perlegen Sciences, NexMed and Eden Biodesign have all had people on the move in the world of pharmaceutical manufacturing.

Biomarker market predicted to 'explode'

07-Nov-2007 - The global market for biomarkers is expected to more than double over the next 5 years to reach an estimated $12.8bn (€8.7bn), according to a new market research report.

DSM third quarter results

07-Nov-2007 - DSM's third quarter financial results are paving the way for the company's transition to a life sciences and material sciences company.

New firm to tackle poor solubility head on

07-Nov-2007 - A new Belgian company has joined the throng of pharmas tapping into the booming drug delivery business, but claims that its unique technologies will carve it a place as one...

New counterfeit report highlights worrying trends

07-Nov-2007 - A new report highlights a number of worrying trends emerging in regard to the increasing number of fake pharmaceuticals infiltrating supply chains around the globe.

New oral film takes the heat out of manufacturing

07-Nov-2007 - Another oral dissolvable film has been developed, with the formulation and manufacturing process potentially giving the strip a production advantage.

Contract manufacturing news in brief

06-Nov-2007 - Bioserv Corporation, Mikart, Laureate Pharma, Cenexi and Lonza have all recently announced new contract manufacturing news.

Industry news in brief - week 45

06-Nov-2007 - LabTechnologist.com brings you its periodic round up of industry news with developments at Agilent, Bruker Bioscience, Dolomite, Oxford Gene Technology and Roche Applied Science.

Tecan and GE join forces to aid HT protein purification

06-Nov-2007 - Tecan and GE Healthcare Life Sciences division are collaborating to simplify high throughput (HT) protein purification by increasing the speed and reliability of expression screening programmes.

Mass spectrometry weighs in for genotyping applications

06-Nov-2007 - Commonly the domain of the microarray, mass spectrometry is becoming an increasingly viable alternative for high throughput genotyping with recent research promising to advance its adoption.

New safety warning delays Novartis diabetes drug

06-Nov-2007 - Swiss firm Novartis today announced that it has contacted regulators regarding the safety of the 100mg dose of its recently approved Type II diabetes drug, Galvus (vildagliptin).

Satraplatin ruling in GPC Biotech favour

06-Nov-2007 - GPC Biotech has found a ray of light in the satraplatin quagmire following an arbitration ruling in favour of the Germany-based biopharmaceutical company.

Varian snaps up Analogix in a flash

06-Nov-2007 - Scientific instrument and vacuum technology supplier Varian has acquired the assets of US flash chromatography expert Analogix for $11m (€7.6m) cash plus the assumption of its net debt.

Pharmaceutical patent round-up

06-Nov-2007 - In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations.

Cash injection for anthrax jab

06-Nov-2007 - US firms Medarex and PharmAthene today announced that they are to receive additional funding from the US Government to support the ongoing development of their anthrax therapeutic, Valortim.

Weekly Comment

FDA failure on foreign inspections frightening

05-Nov-2007 - A US government audit has confirmed the Food and Drug Administration's (FDA's) continual lack of inspection of foreign drug manufacturing plants.

Japan's Tamiflu supply halved

05-Nov-2007 - Japan will only be receiving 50 per cent of its usual supply of the blockbuster flu drug Tamiflu (oseltamivir) this year, thanks to significantly reduced demand following reports of suicidal...

Sigma-Aldrich halves miRNA preparation times

05-Nov-2007 - Sigma-Aldrich has continued its push into the RNAi field with the launch of its new mirPremier miRNA (microRNA) isolation kit that promises to speed up miRNA preparation while removing all...

Neural stem cell drug delivery is encapsulating

05-Nov-2007 - Inherited genetic disorders could be treated with a new stem cell-based drug delivery therapy through the use of microcapsules.

GSK, Fabre-Kramer lose out on antidepressant

05-Nov-2007 - GlaxoSmithKline (GSK) and Fabre-Kramer Pharmaceuticals (FKP) were dealt a blow last week as their potential first in class, once-daily antidepressant treatment received another thumbs down from US regulators.

Flutiform safety results a 'significant milestone'

05-Nov-2007 - UK-based SkyePharma has been given a boost in regards to its asthma treatment following the release of positive Phase III results.

Weekly Comment

Pharma must 'reinvent' itself to survive

02-Nov-2007 - With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to...

Pharmaceutical manufacturing: news in brief

02-Nov-2007 - In-PharmaTechnologist.com brings you a selection of other headlines from the pharmaceutical manufacturing industry.

Valeritas insulin delivery device gets a name

02-Nov-2007 - US-based Valeritas has announced the brand name for its lead candidate disposable insulin delivery device - V-Go.

Product news in brief - week 44

01-Nov-2007 - LabTechnologist.com brings you its periodic round up of product news, with announcements from Air Science, Beckman Coulter, Bio-Rad, Biohit, Carl Zeiss SMT, Proxeon, Shimadzu and Thermo Fisher Scientific.

Nikon halves imaging time with new integrated microscope

01-Nov-2007 - Nikon has launched a new inverted microscope range that promises to more than half the time of an imaging experiment while enabling more simultaneous applications.

SCOLR on track for first 12-hour ibuprofen

01-Nov-2007 - SCOLR Pharma has initiated the first of three pivotal trials to evaluate its extended release ibuprofen tablet, with hopes that it will be the first and only 12-hour formulation on...

Cells caught in a 'tractor beam'

01-Nov-2007 - US researchers have developed a 'tractor beam' that that can pick up, hold and move individual cells around a microchip surface - paving the way for more sensitive biological devices.

Future of satraplatin uncertain

01-Nov-2007 - GPC Biotech has met another obstacle in its path towards satraplatin approval after the German company announced disappointing and unexpected results in its Phase III trial.

GSK blocks new patent rules

01-Nov-2007 - Just a day before they were due to come into force, GlaxoSmithKline has won a court case to block controversial changes to patent rules.

Genentech Avastin decision 'hard to overlook'

01-Nov-2007 - Despite Genentech's recent decision to push out the cut-off date to ban the sale of cancer drug Avastin (bevacizumab) to compounding pharmacies in the US to restrict off-label use, ophthalmologists...

Gene Logic drops genomics and name for drug repositioning

01-Nov-2007 - After selling of its genomics business to Ocimum Biosolutions, Gene Logic is to change its name to Ore Pharmaceuticals as it looks to mine out new indications for drugs.